Palvella Therapeutics (NASDAQ:PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for QTORIN rapamycin in Microcystic Lymphatic Malformations, after reporting what executives described as positive Phase 3 results and outlining an expanded commercial plan suppor
QuinStreet (NASDAQ:QNST) reported record fiscal third-quarter revenue and adjusted EBITDA, with executives pointing to strength in auto insurance, home services and expanded use of artificial intelligence across the company’s platform.
Chief Executive Officer Doug Valenti said revenue rose 28% year
Quantum-Si (NASDAQ:QSI) reported first-quarter 2026 revenue of $258,000 and reiterated that the year will be a transition period focused on development and market preparation for its next-generation Proteus protein sequencing platform.
President and Chief Executive Officer Jeff Hawkins said the com
Peloton Interactive (NASDAQ:PTON) executives said the company returned to year-over-year revenue growth in its fiscal third quarter and is moving from a turnaround phase toward what CEO and President Peter Stern described as “strategic optionality,” supported by stronger cash flow, lower net debt an
PubMatic (NASDAQ:PUBM) reported first-quarter 2026 results that topped its guidance, with management pointing to growth in its underlying business, adoption of AI tools and expansion in connected TV, mobile app and emerging revenue streams.
Co-Founder and CEO Rajeev Goel said the company delivered
Hyperliquid Strategies (NASDAQ:PURR) reported a profitable fiscal third quarter, with results driven primarily by appreciation in the HYPE token and continued staking revenue, executives said on the company’s third-quarter 2026 earnings call.
CEO David Schamis said the company remains “by far the l
IREN shares soar on a $3.4 billion AI cloud infrastructure deal with Nvidia. But does that warrant buying IREN stock at current levels? Let’s find out!
BCP Investment Corporation reported higher investment income and stable core earnings for the first quarter of 2026, while management said a decline in net asset value was primarily tied to unrealized markdowns concentrated in software and software-exposed holdings.
Chief Executive Officer Ted Gold
C.H. Robinson Worldwide (NASDAQ:CHRW) shareholders approved all four proposals presented at the company’s 2026 Annual Meeting of Shareholders, including the re-election of 10 directors, an advisory vote on executive compensation, the ratification of Deloitte & Touche LLP as the company’s indepen
Polestar Automotive Holding UK (NASDAQ:PSNY) reported higher first-quarter 2026 vehicle volumes but a wider loss, as management said pricing pressure, tariffs and seasonality offset cost-cutting efforts in a more difficult electric vehicle market.
Chief Executive Michael Lohscheller said Polestar d
Personalis (NASDAQ:PSNL) reported first-quarter 2026 revenue of $15.5 million as management said the company is prioritizing growth in its clinical minimal residual disease, or MRD, testing business and biopharma MRD programs over lower-margin legacy enterprise revenue.
Chief Executive Officer Chri
PTC Therapeutics (NASDAQ:PTCT) reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.
Chief Executive Officer Dr. Matthew Klein said the company is “off to a terrific start to 2026
CarParts.com (NASDAQ:PRTS) reported its first positive adjusted EBITDA since the first quarter of 2024, as executives said cost reductions, advertising discipline and operational changes helped offset lower revenue in the first quarter of fiscal 2026.
The online auto parts retailer posted adjusted
Profound Medical (NASDAQ:PROF) reported sharply higher first-quarter revenue and reiterated its view that adoption of its TULSA prostate treatment platform is moving toward broader commercial use, supported by new clinical data, payer progress and a growing installed base.
For the three months ende
Privia Health Group (NASDAQ:PRVA) reported a strong first quarter, with executives pointing to double-digit provider growth, a larger value-based care population and margin expansion as signs that the company’s operating model continues to scale.
Chief Executive Officer Parth Mehrotra said Privia “
Prospect Capital (NASDAQ:PSEC) reported net investment income of $78 million, or $0.16 per common share, for its March quarter, as management emphasized a continuing shift toward first-lien senior secured middle-market lending and away from structured notes, real estate and other targeted equity-lin
There's real potential to double your $7,000 TFSA contribution over time with a combination of price gains and dividend income from quality dividend-paying stocks.
The Schwab U.S. Dividend Equity ETF and the Vanguard Total Stock Market ETF are both terrific funds. But one has the edge in terms of long-term growth potential.
Angel Oak UltraShort Income ETF offers a higher-yielding alternative to money market funds, with a diversified portfolio of short-duration fixed income and securitized credit.
The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.84%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +2.35%. June E-mini S&P futures (ESM26 ) rose +0.79%, and June...
TELUS delivered record free cash flow and Canada's best churn rate. Meanwhile, BCE is rebuilding. Which Canadian telecom stock is a better buy for TFSA investors.
